Increased Thrombogenicity in Chronic Renal Failure in a Rat Model Induced by 5/6 Ablation/Infarction

키워드

참고문헌 (36)

1. Shlipak MG, "Cystatin C and the risk of death and cardiovascular events among elderly persons", N Engl J Med, 352, pp.2049~2060 (2005)[DOI]
2. 강용운, "Concomitant Impact of High-Sensitivity C-Reactive Protein and Renal Dysfunction in Patients with Acute Myocardial Infarction", Yonsei Medical Journal, 55(1), pp.132~140 (2014), 연세대학교의과대학
3. 김경섭, "Histopathological Findings of Intracranial Thrombi in Nonbacterial Thrombotic Endocarditis", 대한뇌졸중영문학회지, 19(3), pp.367~369 (2017), 대한뇌졸중학회
4. Casserly LF, "Thrombosis in end-stage renal disease", Semin Dial, 16, pp.245~256 (2003)[DOI]
5. Wattanakit K, "Chronic kidney disease increases risk for venous thromboembolism", J Am Soc Nephrol, 19, pp.135~140 (2008)[DOI]
6. Huang Y, "PAI-1 as a target in kidney disease", Curr Drug Targets, 8, pp.1007~1015 (2007)[DOI]
7. Hrafnkelsdottir T, "Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertension", Hypertension, 44, pp.300~304 (2004)[DOI]
8. Lutz J, "Haemostasis in chronic kidney disease", Nephrol Dial Transplant, 29, pp.29~40 (2014)[DOI]
9. Jalal DI, "Disorders of hemostasis associated with chronic kidney disease", Semin Thromb Hemost, 36, pp.34~40 (2010)[DOI]
10. Chevalier RL, "Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy", Kidney Int, 75, pp.1145~1152 (2009)[DOI]
11. Rossini M, "Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy", Nephrol Dial Transplant, 25, pp.1803~1810 (2010)[DOI]
12. Bing P, "Expression of renal transforming growth factor-beta and its receptors in a rat model of chronic cyclosporine-induced nephropathy", Transplant Proc, 38, pp.2176~2179 (2006)[DOI]
13. Yang HC, "Models of chronic kidney disease", Drug Discov Today Dis Models, 7, pp.13~19 (2010)[DOI]
14. Lee SY, "Renal ischemiareperfusion injury causes intercalated cell-specific disruption of occludin in the collecting duct", Histochem Cell Biol, 136, pp.637~647 (2011)[DOI]
15. Kwon I, "Thrombolytic effects of the snake venom disintegrin saxatilin determined by novel assessment methods: a FeCl3-induced thrombosis model in mice", PLoS One, 8, pp.e81165~ (2013)[DOI]
16. Gava AL, "Effects of 5", 6 nephrectomy on renal function and blood pressure in mice, 2012, pp.4, 167~173
17. Erdely A, "Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase", J Am Soc Nephrol, 14, pp.2526~2533 (2003)[DOI]
18. Degaspari S, "Altered KLOTHO and <TEX>$NF-{\kappa}B-TNF-{\alpha}$<", TEX> signaling are correlated with nephrectomy-induced cognitive impairment in rats, 2015, pp.10, e0125271~
19. Camenzind V, "Citrate storage affects Thrombelastograph analysis", Anesthesiology, 92, pp.1242~1249 (2000)[DOI]
20. Meyer AS, "Thrombelastography and rotational thromboelastometry early amplitudes in 182 trauma patients with clinical suspicion of severe injury", J Trauma Acute Care Surg, 76, pp.682~690 (2014)[DOI]
21. Cruz MV, "Reference ranges for rotational thromboelastometry in male Sprague Dawley rats", Thromb J, 15, pp.31~ (2017)[DOI]
22. Cook NS, "Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb", IIIa antagonists, 1993, pp.70, 531~539
23. Kurz KD, "Rat model of arterial thrombosis induced by ferric chloride", Thromb Res, 60, pp.269~280 (1990)[DOI]
24. Farrehi PM, "Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice", Circulation, 97, pp.1002~1008 (1998)[DOI]
25. Mangin P, "Thrombin overcomes the thrombosis defect associated with platelet GPVI", FcRgamma deficiency, 2006, pp.107, 4346~4353
26. Molino D, "Coagulation disorders in uremia", Semin Nephrol, 26, pp.46~51 (2006)[DOI]
27. Johansson PI, "Coagulation monitoring of the bleeding traumatized patient", Curr Opin Anaesthesiol, 25, pp.235~241 (2012)[DOI]
28. Kaikita K, "Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis", J Pathol, 188, pp.180~188 (1999)[DOI]
29. Pawlak K, "Tissue factor", its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment, 2009, pp.20, 590~594
30. Furie B, "Mechanisms of thrombus formation", N Engl J Med, 359, pp.938~949 (2008)[DOI]
31. Waki K, "Measuring platelet aggregation in dialysis patients with a whole blood aggregometer by the screen filtration pressure method", Ther Apher Dial, 15, pp.203~206 (2011)[DOI]
32. Tay KH, "What "drives" the link between the renin-angiotensin-aldosterone system and the prothrombotic state in hypertension?", Am J Hypertens, 21, pp.1278~1279 (2008)[DOI]
33. Zeck J, "Whole blood platelet aggregation and release reaction testing in uremic patients", Biomed Res Int, 2013, pp.486290~ (2013)
34. Chen GF, "In vivo renal arginine release is impaired throughout development of chronic kidney disease", Am J Physiol Renal Physiol, 298, pp.F95~F102 (2010)[DOI]
35. Mannucci PM, "Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia", N Engl J Med, 308, pp.8~12 (1983)[DOI]
36. Remuzzi G, "Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect", J Clin Invest, 71, pp.762~768 (1983)[DOI]

관련 논문AI추천